Inga M. Kotieva

Inga M. Kotieva

Auto-generated profile, based on publicly available information

Inga M. Kotieva

Rostov State Medical University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 December 2021 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
MDMargarita A. Dodokhova
Margarita A. Dodokhova
ASAndrei V. Safronenko
Andrei V. Safronenko
IKInga M. Kotieva
Inga M. Kotieva
MAMargarita S. Alkhuseyn-Kulyaginova
Margarita S. Alkhuseyn-Kulyaginova
DSDmitry B. Shpakovsky
Dmitry B. Shpakovsky
Elena R. MilaevaElena R. Milaeva
Elena R. Milaeva
Introduction: Search for new compounds with a broad antitumor and antimetastatic potency due to multiple targeting remains important in medicinal chemistry, pharmacology and oncology. We report the efficacy of hybrid organotin agents bis-(3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethyltin (Ме3) and (3,5-di-tert-butyl-4-hydroxyphenylthiolate) triphenyltin (Ме5). Materials and methods: The compounds were administered to mice bearing the spontaneously metastatic epidermoid Lewis lung carcinoma (LLC). The efficacy of the treatment was evaluated by mean life span, percentage of tumor growth inhibition, number of lung metastases, frequency of metastasis, tumor weight 21 days after tumor cell inoculation, and a degree of lung damage according to the method of D. Tarin and J.E. Price. Results and discussion: For new organotin compounds containing an antioxidant protective fragment of 2,6-di-tert-butylphenol, moderate antitumor and pronounced antimetastatic effects were revealed in the Lewis model of epidermoid lung carcinoma; more active for Me5. Some features of the development of the process of metastasis were recorded with the introduction of various doses of hybrid organotin compounds. Conclusion: Substances Ме3 and Ме5 possess specific activity on the model under investigation, which allows one to suggest these organotins as promising series of antitumor and antimetastatic agents with multiple targeting mode of action.

11 November 2021 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
MDM. A. Dodokhova
M. A. Dodokhova
ASA. V. Safronenko
A. V. Safronenko
IKI. M. Kotieva
I. M. Kotieva
EKE. F. Komarova
E. F. Komarova
ВТВ. Г. Трепель
В. Г. Трепель
Elena R. MilaevaElena R. Milaeva
Elena R. Milaeva
The aim of the study was to evaluate the safety of the use of organotin compounds containing a fragment of 2,6-di-tert-butylphenol as pharmaceutical substances when administered intragastrically to Wistar outbred rats (females). Material and methods. The objects of the study were three organotin compounds: ((3,5-di-tertbutyl-4-hydroxyphenylthiolate) triphenyltin (Me-5), (3,5-di-tert-butyl-4-hydroxyphenylthiolate)trimethyltin (Me-4), bis(3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethyltin (Me-3). Acute toxicity study were performed on 106 Wistar rats (female) weighing 190-210 g by "fixed dose" and "up and down" methods according to the OECD protocols. Results. According to the harmonized system of hazard classification and labeling of chemical products (GHS) the studied organotin compounds should be assigned to the following toxicity classes: Me-5 — IV, Me-3 — V, Me-4 — II. Average lethal dose in intragastric administration for Me-5 is LD50 = 955.0 ± 58.3 mg/kg, the value of LD50 for Me-3 is conventionally assumed to be much more than 2000 mg/kg, for Me-4 is in the range of 5 to 50 mg/kg. Discussion. The modification of tin-organic molecules in the course of directed synthesis opens broad prospects for the creation of a new class of anticancer drugs. In the course of the experimental study, the regularities of the "structure-toxicity" relationship of organic tin derivatives were revealed: the introduction of the 2,6-di-tert-butylphenol group significantly reduces toxicity compared to the corresponding initial substances; methyl derivatives are more toxic than their phenyl analogues. Compounds of GHS toxicity classes IV and V can be considered as leading candidates for promising preclinical studies in the field of experimental oncology. Conclusion. Substances of Me-3 and Me-5, which have the highest safety for intragastric use, were recommended for further study as antitumor drug agents.

9 November 2021 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
MDM. A. Dodokhova
M. A. Dodokhova
IKI. M. Kotieva
I. M. Kotieva
АSА. V. Safronenko
А. V. Safronenko
ВТВ. Г. Трепель
В. Г. Трепель
MAM. S. Alkhuseyn–Kulyaginova
M. S. Alkhuseyn–Kulyaginova
Elena R. MilaevaElena R. Milaeva
Elena R. Milaeva
Introduction. The aim of the study was to evaluate the effect of hybrid organotin compounds bis(3,5–di– tert–butyl–4–hydroxyphenylthiolate) dimethylol (Me3) and ((3,5–di–tert–butyl–4–hydroxyphenylthiolate) triphenylolol (Me5) on the level of markers of oxidative stress and apoptotic processes in the mitochondria during acute and subchronic intragastric administration to Wistar rats (females) in the maximum tolerated dose. Materials and methods. The objects of study were hybrid organotin compounds, the administration was carried out at the maximum tolerated dose of 2000 mg/kg (Me3) and 750 mg/kg (Me5) with a single and multiple intragastric administration. The study was conducted on 60 Wistar rats (females) weighing 190-210g. The concentration of cytochrome C (ng / g protein), caspase-9(ng / g protein), 8-hydroxy-2' — deoxyguanosine (8-OHdG) (ng/g protein), malondialdehyde (MDA) (nM / g protein)was determined in mitochondrial liver samples using test systems by enzyme immunoassay; by the biochemical method-the amount of protein (mg / ml) — by the biuretic method. Results. Me3 in both series of the experiment showed itself as a more pronounced antioxidant than Me5, which did not show its antioxidant properties. In group I animals, there were no statistically significant differences in the level of MDA and Cit C in relation to the control group, no mitDNA damage was detected, but K9 activity increased by 17%. With the introduction of Me5, the value of the MDA indicator increased by 55.5%, 8 — OHdG by 12.4% and Cit C by 66.2%. In group IV, the amount of MDA as the final product of lipid peroxidation (POL) increased by 13.6%, in group V by 22.5%. With the introduction of Me3, the level of Cit C was reduced by 23.5%, with the introduction of Me5, on the contrary, it was slightly increased. K9 activity was reduced in both experimental groups, by 9.6% and 17.3%, respectively. Discussion. Hybrid OOS containing a fragment of 2,6-di-tert-butylphenol have a dual structure. The tin-containing component is prooxidant, and the radical of the spatially hindered phenol, on the contrary, is antioxidant. It is the different ratio of the described fragments in the molecules of the substances under study, in our opinion, that led to the appearance of different degrees of influence on the metabolism of mitochondria. Conclusion. Both substances that modulate changes in oxidative stress and the activity of apoptotic processes are recommended for further research as antitumor medicinal agents.

1 September 2022 in South Russian Journal of Therapeutic Practice
Verified
Journal Article
Open access
PDF file
MDM. A. Dodokhova
M. A. Dodokhova
IKI. M. Kotieva
I. M. Kotieva
ASA. V. Safronenko
A. V. Safronenko
SSS. V. Shlyk
S. V. Shlyk
NDN. V. Drobotya
N. V. Drobotya
DSD. B. Shpakovsky
D. B. Shpakovsky
The search for new antitumor and antimetastatic therapy targets is a priority task for interdisciplinary research in medical chemistry, experimental pharmacology and pathological physiology. One of the promising scopes of research in this direction is to study the possibility of modifying the polymerization process of tubulin, the main structural component of the microtubules in the cellular cytoskeleton. Various options for influencing microtubules can be used to repurpose already known and develop new antitumor drugs.

20 September 2021 in Экспериментальная и клиническая фармакология
Verified
Journal Article
Closed access
PDF file
МДМаргарита Авдеевна Додохова
Маргарита Авдеевна Додохова
МКМаргарита Стефановна Алхусейн – Кулягинова
Маргарита Стефановна Алхусейн – Кулягинова
АСАндрей Владимирович Сафроненко
Андрей Владимирович Сафроненко
ИКИнга Мовлиевна Котиева
Инга Мовлиевна Котиева
ДШДмитрий Борисович Шпаковский
Дмитрий Борисович Шпаковский
Elena R. MilaevaElena R. Milaeva
Elena R. Milaeva
На модели перевиваемой опухоли эпидермоидной карциномы Lewis в экспериментах на мышах (самки) линии C57Bl/6 изучали противоопухолевое и антиметастатическое действие комбинированной терапии цисплатином и гибридным оловоорганическим соединением (Ме5) при курсовом внутрибрюшинном введении в малых дозах. Показано, что при пятикратном внутрибрюшинном введении исследуемых соединений в сочетанном режиме наблюдался синергический тип взаимодействия. На 21 сут после перевивки опухолевого материала у животных опытной группы размер первичного опухолевого узла уменьшился на 25 %, а также снизилась интенсивность метастазирования на 32 %, p ≤ 0,05.

27 October 2023 in Ural Medical Journal
Verified
Journal Article
Open access
PDF file
MDM. A. Dodokhova
M. A. Dodokhova
MAM. A. Akimenko
M. A. Akimenko
OVO. V. Voronova
O. V. Voronova
MAM. S. Alkhuseyn-Kuliaginova
M. S. Alkhuseyn-Kuliaginova
EKElizaveta Mikhailovna Kotieva
Elizaveta Mikhailovna Kotieva
IKI. M. Kotieva
I. M. Kotieva
Introduction The search for new compounds with putative antitumor effects and the development of domestic anticancer and antimetastatic drugs based on them is a priority task for specialists in the field of medical chemistry, experimental pathophysiology and pharmacology. Melanoma B16 and Lewis lung epidermoid carcinoma are universal models for evaluating the effect of compounds with putative antitumor action on the primary focus of tumor growth and the process of tumor cells dissemination.The aim of the work is to determine the feasibility of using models of solid tumor growth and metastasis activity of Lewis lung epidermoid carcinoma and B16 melanoma for preclinical studies of antitumor and antimetastatic pharmacological activity of hybrid organotin compounds depending on experimental objectives.Materials and methods The experimental part was performed on C57B1/6 mice (females). Hybrid organotin compounds were administered five times, intraperitoneal, the beginning of treatment – 48 hours after tumor cells transplantation in the same regimes for both models. In this work, the most effective (375 mg/kg and 250 mg/kg, respectively) and toxic (500 mg/kg and 375 mg/kg, respectively) doses of the leader hybrid organotin compounds Me3 (bis(3,5-di-tert-butyl-4-hydroxyphenylthiolate) dimethytin) and Me5 ((3,5-di-tert-butyl-4-hydroxyphenylthiolate)triphenyltin) were used.Results At all stages of the experiment on both models of tumor growth we obtained similar results characterizing the pharmacological activity of the tested compounds: moderate antitumor and high antimetastatic effect. The rates of growth and tumor process development are comparable and convenient for planning preclinical studies in vivo and can be interchangeable.Discussion The Lewis lung model of epidermoid carcinoma has a higher degree of convenience for data interpretation (number of metastatic foci in the lungs) when conducting exploratory analysis of pharmacological activity in a wide range of doses. When studying pathogenetic peculiarities of metastasis under the action of compounds with presumed antitumor action due to the possibilities of contrast immunohistochemical staining of tumor cells, the B16 melanoma model has an advantage. In our experiment with immunohistochemical staining for Melan A the hematogenic pathway of metastasis through the bloodstream is clearly traced.Conclusion For exploratory screening studies to select promising candidates for in-depth study it is reasonable to use the Lewis lung epidermoid carcinoma model. The B16 melanoma model is more informative for in-depth study of compounds that have proven to be effective.